Case Control Study
Copyright ©The Author(s) 2024.
World J Clin Cases. May 6, 2024; 12(13): 2160-2172
Published online May 6, 2024. doi: 10.12998/wjcc.v12.i13.2160
Table 4 Bile acid levels in colonic polyps of different pathological types (nmol/L)
Non adenomatous polyp group
Adenomatous polyp group
P value
Primary free BAs
        CA107.00 (39.50, 357.00)53.20 (20.35, 185.50)0.003a
        CDCA408.00 (191.00, 1130.00)373.00 (80.50, 785.00)0.034a
Primary conjugated BAs
        TCA24.80 (8.90, 71.50)20.10 (5.45, 45.80)0.189
        GCA160.00 (81.70, 423.00)174.00 (72.60, 326.00)0.676
        GCDCA866.00 (458.00, 2190.00)961.00 (397.00, 1785.00)0.465
        TCDCA113.00(40.70, 185.00)64.50 (24.60, 152.50)0.060
Secondary free BAs
        DCA182.00 (38.50, 448.00)118.00 (21.25, 401.00)0.226
        LCA5.30 (0.00, 16.80)6.70 (0.50, 17.20)0.588
        UDCA107.00 (49.00, 311.00)64.00 (16.15, 190.00)0.003a
Secondary conjugated BAs
        TDCA17.90 (2.50, 39.10)6.80 (0.00, 24.35)0.078
        GDCA135.00 (7.40, 398.00)107.00 (19.25, 229.00)0.593
        TLCA0.00 (0.00, 2.10)0.00 (0.00, 2.55)0.566
        GLCA4.40 (0.00, 20.30)4.60 (0.00, 15.50)0.646
        TUDCA11.70 (4.50, 20.10)6.50 (2.95, 15.00)0.023a
        GUDCA220.00 (58.10, 543.00)114.00 (43.55, 303.00)0.067
aP < 0.05, there is a statistical difference in this indicator between the two groups.
BA: Bile acid; CA: Cholic acid; CDCA: Chenodeoxycholic acid; TCA: Taurocholic acid; GCA: Glycocholic acid; TCDCA: Taurochenodeoxycholic acid; GCDCA: Glycochenodeoxycholic acid; DCA: Deoxycholic acid; UDCA: Ursodeoxycholic acid; LCA: Lithocholic acid; TDCA: Tauroursodeoxycholic acid; GDCA: Glycodeoxycholic acid; TUDCA: Tauroursodeoxycholic acid; GUDCA: Glycoursodeoxycholic acid; TLCA: Taurolithocholic acid; GLCA: Glycolithocholic acid.